![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
662kB |
| Item Type: | Review |
|---|---|
| Title: | Microbiota in health and disease-potential clinical applications |
| Creators Name: | Laudes, M., Geisler, C., Rohmann, N., Bouwman, J., Pischon, T. and Schlicht, K. |
| Abstract: | Within the last two decades tremendous efforts in biomedicine have been undertaken to understand the interplay of commensal bacteria living in and on our human body with our own human physiology. It became clear that (1) a high diversity especially of the microbial communities in the gut are important to preserve health and that (2) certain bacteria via nutrition-microbe-host metabolic axes are beneficially affecting various functions of the host, including metabolic control, energy balance and immune function. While a large set of evidence indicate a special role for small chain fatty acids (SCFA) in that context, recently also metabolites of amino acids (e.g., tryptophan and arginine) moved into scientific attention. Of interest, microbiome alterations are not only important in nutrition associated diseases like obesity and diabetes, but also in many chronic inflammatory, oncological and neurological abnormalities. From a clinician's point of view, it should be mentioned, that the microbiome is not only interesting to develop novel therapies, but also as a modifiable factor to improve efficiency of modern pharmaceutics, e.g., immune-therapeutics in oncology. However, so far, most data rely on animal experiments or human association studies, whereas controlled clinical intervention studies are spare. Hence, the translation of the knowledge of the last decades into clinical routine will be the challenge of microbiome based biomedical research for the next years. This review aims to provide examples for future clinical applications in various entities and to suggest bacterial species and/or microbial effector molecules as potential targets for intervention studies. |
| Keywords: | Microbiome, Gastroenterology, Oncology, Neurology, Animals |
| Source: | Nutrients |
| ISSN: | 2072-6643 |
| Publisher: | MDPI |
| Volume: | 13 |
| Number: | 11 |
| Page Range: | 3866 |
| Date: | 29 October 2021 |
| Official Publication: | https://doi.org/10.3390/nu13113866 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
